Distinguishing Between Anti-PD-1 Agents in ESCC Combination Therapies
Jaffer Ajani, MD
ICI Combination Regimens for First-Line Treatment of Metastatic ESCC
Harry Yoon, MD
Effective Monitoring and Management of Adverse Effects in Metastatic ESCC
The Impact of First-Line Treatment on Subsequent Treatment Options for Metastatic ESCC
AF and VTE: Global Considerations in the Evolving Space of Real-World Data
Renato D. Lopes, MD, MHS, PhD
Valeria Caso, MD, PhD
Alexander T. Cohen, MD, MBBS
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: VTE Considerations
Patient Case Study: Obesity
Patient Case Study: Elderly
Patient Case Study: Obesity and VTE
Patient Case Study: Cancer-Associated Thrombosis
How Do We Translate Real-World AF Data Into Everyday Clinical Practice?
How Do We Translate Real-World VTE Data Into Everyday Clinical Practice for Ongoing Anticoagulation?
Implications Associated With Integrating Both Real-World Data and Clinical Trial Data Into Clinical Practice: AF Considerations
Trade off: Ischemic/Thrombotic vs Bleeding
Setting the Stage of Real-World Data vs RCT
Right Heart Catheterization: Mastery of Precision Techniques
Richard Krasuski, MD
Vallerie V. McLaughlin, MD
Loading...
We're glad to see you're enjoying MedEd On The Go… but how about a more personalized experience?
Press cancel to remain on MedEd On The Go. Press the link below or the continue button to keep going.